Export

EN
FR
Meropenem
Essential medicine status
Section:
6. Anti-infective medicines 6.2. Antibacterials 6.2.5. Antituberculosis medicines
ATC codes: J01DH02
EMLc
Indication
Multi-drug resistant Mycobacterium tuberculosis ICD11 code: ML32.00
INN
Meropenem
Medicine type
Chemical agent
Antibiotic groups
WATCH
List type
Core (EML)
(EMLc)
Additional notes
The square box applies only to the listing of meropenem on the EML.
Formulations
Parenteral > General injections > IV: 500 mg in vial (as trihydrate) powder for injection ; 1 g in vial (as trihydrate) powder for injection
EML status history
First added in 2019 (TRS 1021)
Changed in 2021 (TRS 1035)
Changed in 2025 (TRS 1064)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
imipenem + cilastatin (ATC codes: J01DH51)
Patent information
Patents have expired in most jurisdictions
Wikipedia
Meropenem
DrugBank
Meropenem
Summary of evidence and Expert Committee recommendations
The Expert Committee recommended the transfer of listings for medicines for multi-drug resistant tuberculosis from the complementary to the core list of the EML and EMLc.